<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04881526</url>
  </required_header>
  <id_info>
    <org_study_id>21-02-019</org_study_id>
    <nct_id>NCT04881526</nct_id>
  </id_info>
  <brief_title>Ketone Ester Supplementation on Neuro-cardiovascular Responses to Stress in Humans</brief_title>
  <official_title>Ketone Ester Supplementation on Neuro-cardiovascular Responses to Stress in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ketone ester supplementation has become increasingly popular as an athletic supplement.&#xD;
      However, the metabolic effects of these supplements on exercise performance are&#xD;
      controversial. One potential reason for lack of an ergogenic benefit could be the effects of&#xD;
      ketone bodies on other bodily systems, such as the sympathetic nervous system. During&#xD;
      exercise and stress the body increases the activity of the sympathetic nervous system. This&#xD;
      causes blood vessels to constrict (get smaller) and can increase blood pressure. Studies have&#xD;
      shown that ketone bodies can suppress the sympathetic nervous system in mice. Additionally,&#xD;
      ketone ester supplementation can reduce blood pressure in healthy adults. In humans, direct&#xD;
      measures of sympathetic activity are usually made from sympathetic outflow to muscle, also&#xD;
      called muscle sympathetic nerve activity (MSNA). Using a ketone ester supplement, the&#xD;
      investigators plan to measure blood pressure and sympathetic outflow to muscle at rest and&#xD;
      during handgrip exercise and a mathematical task stress test to investigate the effect of&#xD;
      ketones on neuro-cardiovascular stress responses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle sympathetic nerve activity</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Microneurography of fibular nerve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle sympathetic nerve activity</measure>
    <time_frame>Post-intervention - Immediately following active and control interventions</time_frame>
    <description>Microneurography of fibular nerve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Finger plethysmography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Post-intervention - Immediately following active and control interventions</time_frame>
    <description>Finger plethysmography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forearm blood flow</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Brachial artery Doppler ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forearm blood flow</measure>
    <time_frame>Post-intervention - Immediately following active and control interventions</time_frame>
    <description>Brachial artery Doppler ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ketosis</condition>
  <arm_group>
    <arm_group_label>Ketone ester drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D-beta-hydroxybutyrate</intervention_name>
    <description>Drink containing D-beta-hydroxybutyrate administered at a dose of 395 mg/kg.</description>
    <arm_group_label>Ketone ester drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Isocaloric flavored water with medium-chain triglyceride oil.</description>
    <arm_group_label>Placebo drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 to 40 years of age&#xD;
&#xD;
          -  Healthy, free of known cardiovascular, metabolic, or musculoskeletal disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of smoking (within 3 months), diagnosed cardiovascular or metabolic disease,&#xD;
             recent musculoskeletal injury preventing handgrip exercise, prescription of chronic&#xD;
             medications other than oral contraceptives.&#xD;
&#xD;
          -  Current or recent (within 6 months) use of ketone ester supplementation or&#xD;
             participation in a ketogenic diet.&#xD;
&#xD;
          -  Inability to abstain from drugs, caffeine, alcohol, or strenuous physical activity&#xD;
             prior to the study visit.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Millar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Guelph</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philip Millar, PhD</last_name>
    <phone>5199944906</phone>
    <email>pmillar@uoguelph.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Guelph - Human Cardiovascular Physiology Laboratory</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Millar</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Philip Millar</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

